Skip to main content
SpringerLink
Log in

Suboptimal Use of Antidepressants in the Treatment of Depression

  • Review Article
  • Published:
CNS Drugs Aims and scope Submit manuscript

Abstract

Depression is a common and serious mental illness which is treated mainly in primary care settings. The most common treatment modality is antidepressant medication. Controlled clinical trials have found antidepressants to be effective in the treatment of the acute symptoms of depression and in the prevention of relapse and recurrence of the disorder.

To be effective, antidepressants need to be taken in sufficient doses for adequate periods of time. Many attempts have been made to ensure that the treatments available for depression are applied effectively in clinical practice, mainly through the development and promulgation of consensus guidelines. The various guidelines are consistent in recommending that antidepressants be administered at adequate doses both during the acute phase of treatment and for 4 to 6 months after a response is achieved.

However, optimal use of antidepressants appears to be the exception rather than the rule. Patients who are treated with older tricyclic antidepressants (TCAs) rarely receive doses which have clear evidence of efficacy. Patients taking TCAs or newer antidepressants such as the selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors (SSRIs) commonly stop treatment prematurely. As few as 1 patient in 17 on TCAs, and 1 in 3 on SSRIs, continues treatment at an effective dose for the minimum recommended period of 4 consecutive months.

The patterns of treatment with antidepressants are completely incongruous with the magnitude of burden and risk associated with major depression. This is reflected in evidence of poor outcomes in both the short and longer terms. Failure to treat depression at an early stage contributes to the development of chronic depressive illness. Inadequate doses of antidepressants result in a failure to respond and premature discontinuation increases the risk of relapse; both these patterns of treatment seem to contribute to the development of recurrent depressive episodes.

Despite these findings, suboptimal use of antidepressants in the treatment of depression appears to be universal. It seems that clinicians require clear guidance regarding the crucial importance of recognising depression and initiating effective treatment without delay. They also need information that they regard as credible regarding the vital necessity for patients to receive an effective antidepressant dose for an adequate period of time. There is compelling evidence that this is less likely to be achieved with a TCA than with an SSRI. Given the morbidity and burden caused by depression, centrally coordinated naturalistic studies to investigate the outcomes of suboptimal antidepressant use should be a key priority for government research initiatives.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Fig. 1

Similar content being viewed by others

References

  1. Donoghue JM. Sub-optimal use of tricyclic antidepressants in primary care [editorial]. Acta Psychiatr Scand 1998; 98: 429–31

    Article  PubMed  CAS  Google Scholar 

  2. Weiller E, Lecrubier Y, Boyer P. Antidepressant use in general practice. Therapie 1996; 51: 429–30

    PubMed  CAS  Google Scholar 

  3. Klerman GL, Weissman MM. The course, morbidity, and costs of depression. Arch Gen Psychiatry 1992; 49: 831–4

    Article  PubMed  CAS  Google Scholar 

  4. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results from the medical outcomes study. JAMA 1989; 262: 914–9

    Article  PubMed  CAS  Google Scholar 

  5. Hays RD, Wells KB, Sherbourne CD, et al. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry 1995; 52: 11–9

    Article  PubMed  CAS  Google Scholar 

  6. Simon GE, VonKorff M, Barlow W. Health care costs of primary care patients with recognised depression. Arch Gen Psychiatry 1995; 52: 850–6

    Article  PubMed  CAS  Google Scholar 

  7. Kind P, Sorensen J. The costs of depression. Int Clin Psychopharmacology 1993; 7: 191–5

    Article  CAS  Google Scholar 

  8. Brugha TS. Depression undertreatment: lost cohorts, lost opportunities? Psycholog Med 1995; 25: 3–6

    Article  CAS  Google Scholar 

  9. Pharmacotherapy of depressive disorders: a consensus statement. WHO Mental Health Collaborating Centres. J Affect Disord 1989; 17(2): 197–8

    Article  Google Scholar 

  10. Paykel ES, Priest RG. Recognition and management of depression in general practice: consensus statement. BMJ 1992; 305: 1198–202

    Article  PubMed  CAS  Google Scholar 

  11. Montgomery SA, Bebbington P, Cowen P, et al. Guidelines for treating depressive illness with antidepressants. J Psychopharmacol 1993; 7: 19–23

    PubMed  CAS  Google Scholar 

  12. Clinical Resource and Audit Group. Depressive illness: a critical review of current practice and the way ahead. Consensus statement. Edinburgh: The Scottish Office, National Health Service in Scotland, 1993

    Google Scholar 

  13. Depression Guideline Panel, Agency for Health Care Policy Research Treatment of Major Depression. Clinical practice guideline. No. 5, Vol. 2. Rockville (MD): US Department of Health and Human Services, 1993 (AHCPR Publication No. 93-0550, 1993. 20)

  14. The treatment of depression in primary care: which treatments are effective in the management of depression in primary care? Eff Health Care 1993; 5: 1-12

  15. Selecting an antidepressant. MeReC Bulletin 1995; 6 (I): 1-4

  16. Karasu TB, Docherty JP, Gelenberg A, et al. Practice guideline for major depressive disorder in adults. In: Practice guidelines. Washington, DC: American Psychiatric Association, 1996: 83–127

    Google Scholar 

  17. Crismon ML, Trivedi M, Pigott TA, et al. The Texas medication algorithm project: report of the Texas consensus conference panel on medication treatment of major depressive disorder. J Clin Psychiatry 1999; 60: 142–56

    Article  PubMed  CAS  Google Scholar 

  18. Song F, Freemantle N, Sheldon TA, et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ 1993; 306: 683–7

    Article  PubMed  CAS  Google Scholar 

  19. Anderson IM, Tomenson BM. The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J Psychopharmacol 1994; 8: 238–49

    Article  PubMed  CAS  Google Scholar 

  20. Montgomery SA, Henry J, McDonald G, et al. Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. Int Clin Psychopharmacol 1994; 9: 47–53

    Article  PubMed  CAS  Google Scholar 

  21. Hotopf M, Hardy R, Lewis G. Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. Br J Psychiatry 1997; 170: 120–7

    Article  PubMed  CAS  Google Scholar 

  22. Kendrick T. Prescribing antidepressants in general practice: watchful waiting for minor depression, full dose treatment for major depression. BMJ 1996; 313: 829–30

    Article  PubMed  CAS  Google Scholar 

  23. Paykel ES, Hollyman JA, Freeling P, et al. Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial. J Affect Disord 1988; 14: 83–95

    Article  PubMed  CAS  Google Scholar 

  24. Thompson C, Thompson CM. The prescribing of antidepressants in general practice: II.A placebo-controlled trial of low-dose dothiepin. Hum Psychopharmacol 1989; 4: 191–204

    Article  Google Scholar 

  25. Tyrer P, Murphy S, Kingdon D, et al. The Nottingham study of neurotic disorder: comparison of drug and psychological treatments. Lancet 1988; I: 235–40

    Article  Google Scholar 

  26. Bollini P, Pampallona S, Tibaldi G, et al. Effectiveness of antidepressants: meta-analysis of dose-effect relationships in randomised clinical trials. Br J Psychiatry 1999; 174: 297–303

    Article  PubMed  CAS  Google Scholar 

  27. Thase ME, Sullivan LR. Relapse and recurrence of depression: a practical approach for prevention. CNS Drugs 1995; 4: 261–77

    Article  CAS  Google Scholar 

  28. Maj M, Vietro F, Pirozzi R, et al. Pattern of recurrence of illness after recovery of an episode of major depression: a prospective study. Am J Psychiatry 1992; 149: 795–800

    PubMed  CAS  Google Scholar 

  29. Melfi CA, Chawla AJ, Croghan TW, et al. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry 1998; 55: 1128–32

    Article  PubMed  CAS  Google Scholar 

  30. Johnson DAW. Treatment of depression in general practice. BMJ 1973; 1: 18–20

    Article  CAS  Google Scholar 

  31. Kotin J, Post RM, Goodwin FK. Drug treatment of depressed patients referred for hospitalisation. Am J Psychiatry 1973; 130: 1139–41

    PubMed  CAS  Google Scholar 

  32. Johnson DAW. A study of the use of antidepressant medication in general practice. Br J Psychiatry 1974; 125: 186–92

    Article  PubMed  CAS  Google Scholar 

  33. Johnson DAW. Depression: treatment compliance in general practice. Acta Psychiatr Scand 1981; 63 Suppl. 290: 447–53

    Article  CAS  Google Scholar 

  34. Keller MB, Klerman GL, Lavori PW, et al. Treatment received by depressed patients. J Am Med Assoc 1982; 248: 1848–55

    Article  CAS  Google Scholar 

  35. Jick H, Dinan BJ, Hunter JW, et al. Tricyclic antidepressants and convulsions. J Clin Psychopharmacol 1983; 3: 182–5

    Article  PubMed  CAS  Google Scholar 

  36. Jones L, Simpson D, Brown AC, et al. Prescribing psychotropic drugs in general practice: three year study. BMJ 1984; 289: 1045–8

    Article  PubMed  CAS  Google Scholar 

  37. Pollock BG, Perel JM. Tricyclic antidepressants: contemporary issues for therapeutic practice. Can J Psychiatry 1989; 34: 609–17

    PubMed  CAS  Google Scholar 

  38. Keller MB, Lavori PW, Klerman GL, et al. Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients. Arch Gen Psychiatry 1986; 43: 458–66

    Article  PubMed  CAS  Google Scholar 

  39. Thompson C, Thompson CM. The prescription of antidepressants in general practice: I. A critical review. Hum Psychopharmacol 1989; 4: 91–102

    Article  Google Scholar 

  40. McCombs JS, Nichol MB, Stimmel GL, et al. The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a medicaid population. J Clin Psychiatry 1990; 51 Suppl. 6: 60–9

    Google Scholar 

  41. Katon W, VonKorff M, Lin E, et al. Adequacy and duration of antidepressant treatment in primary care. Med Care 1992; 30: 67–76

    Article  PubMed  CAS  Google Scholar 

  42. Simon GE, VonKorff M, Wagner EH, et al. Patterns of antidepressant use in community practice. Gen Hosp Psychiatry 1993; 15: 399–408

    Article  PubMed  CAS  Google Scholar 

  43. Rosholm J-U, Hallas J, Gram LF. Outpatient utilisation of antidepressants: a prescription database analysis. J Affect Disord 1993; 27: 21–8

    Article  PubMed  CAS  Google Scholar 

  44. Rosholm JU, Gram LF, Damsbo N, et al. Antidepressant treatment in general practice — an interview study. Scand J Prim Care 1995; 13: 281–6

    Article  CAS  Google Scholar 

  45. Munizza C, Tibaldi G, Bollini P, et al. Prescription pattern of antidepressants in out-patient psychiatric practice. Psychologic Med 1995; 25: 771–8

    Article  CAS  Google Scholar 

  46. Bingefors K, Isacson D, von Knorring L. Antidepressant dose patterns in Swedish clinical practice. Int Clin Psychopharmacol 1997; 12(5): 283–90

    Article  PubMed  CAS  Google Scholar 

  47. Donoghue JM, Tylee A, Wildgust HJ. Cross sectional database analysis of antidepressant prescribing in general practice in the United Kingdom, 1993–5. BMJ 1996; 313: 861–2

    Article  PubMed  CAS  Google Scholar 

  48. Matthews K, Eagles JM, Matthews CA. The use of antidepressant drugs in general practice: a questionnaire survey. Euro J Clin Pharmacol 1993; 45: 205–10

    Article  CAS  Google Scholar 

  49. Kerr MR Antidepressant prescribing: a comparison between general practitioners and psychistrists. Br J Gen Pract 1994; 44: 275–6

    PubMed  CAS  Google Scholar 

  50. Thomson RJ. Antidepressant prescribing among referrals to a community mental health unit in New Zealand. Psychiatr Bull 1994; 18: 461–2

    Article  Google Scholar 

  51. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Association, 1980

    Google Scholar 

  52. Donoghue JM. The prescribing of antidepressants in general practice: the use of PACT data (brief report). Postgrad Med J 1994; 70 Suppl. 2: S23–S24

    PubMed  Google Scholar 

  53. Wells KB, Katon W, Rogers B, et al. Use of minor tranquillisers and antidepressant medications by depressed outpatients: results from the Medical Outcomes Study. Am J Psychiatry 1994; 151: 694–700

    PubMed  CAS  Google Scholar 

  54. Arpino C, Da Cas R, Donini G, et al. The use and misuse of antidepressant drugs in a random sample of the population of Rome, Italy. Acta Psychiatr Scand 1995; 92: 7–9

    Article  PubMed  CAS  Google Scholar 

  55. Donoghue JM, Tylee A. The treatment of depression: prescribing patterns of antidepressants in primary care in the United Kingdom. Br J Psychiatry 1996; 168: 164–8

    Article  PubMed  CAS  Google Scholar 

  56. MacDonald TM, McMahon AD, Reid IC, et al. Antidepressant drug use in primary care: a record linkage study in Tayside, Scotland. BMJ 1996; 313: 860–1

    Article  PubMed  CAS  Google Scholar 

  57. World Health Organization. International classification of diseases. 10th ed. Geneva: World Health Organization, 1992

    Google Scholar 

  58. Rouillon F, Blachier C, Dreyfus JP, et al. Etude pharmaco-epidemiologique de la consommation des antidepresseurs en population generale L’encephale Sp 1996; 1: 39–48

    Google Scholar 

  59. Gregor KJ, Hylan TR, van Dijk PCM, et al. Outpatient antidepressant utilisation in a Dutch sick fund. Am J Manage Care 1998; 4: 1150–60

    CAS  Google Scholar 

  60. Isometsa E, Seppala I, Henriksson M, et al. Inadequate dosaging in general practice of tricyclic vs. other antidepressants for depression. Acta Psychiatr Scand 1998; 98: 451–4

    Article  PubMed  CAS  Google Scholar 

  61. Donoghue J, Katona C, Tylee A. The treatment of depression: antidepressant prescribing for elderly patients in primary care. J Pharm 1998; 260: 500–2

    Google Scholar 

  62. Dunn RL, Donoghue JM, Ozminkowski RJ, et al. Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines. J Psychopharmacol 1999; 13(2): 136–43

    Article  PubMed  CAS  Google Scholar 

  63. Donoghue JM. Selective serotonin re-uptake inhibitor use in primary care: a five year naturalistic study. Clin Drug Invest 1998 Dec; 16(6): 453–62

    Article  CAS  Google Scholar 

  64. Tylee A, Gastpar M, Lepine J-P, et al. DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability, and current management of depression in the community. DEPRES Steering Committee. Int Clin Psychopharmacol 1999; 14(3): 139–51

    Article  CAS  Google Scholar 

  65. Keller MB, Klerman GL, Lavori PW, et al. The persistent risk of chronicity in recurrent episodes of non-bipolar major depressive disorder: a prospective follow-up. Am J Psychiatry 1986; 143: 24–8

    PubMed  CAS  Google Scholar 

  66. Kiloh LG, Andrews G, Neilson M. The long-term outcome of depressive illness. Br J Psychiatry 1988; 153: 752–7

    Article  PubMed  CAS  Google Scholar 

  67. Goethe JW, Szarek BL, Cook WL. A comparison of adequately vs. Inadequately treated depressed patients. J Nerv Ment Dis 1988; 176: 465–70

    Article  PubMed  CAS  Google Scholar 

  68. Scott J. Chronic depression. Br J Psychiatry 1988; 153: 287–97

    Article  PubMed  CAS  Google Scholar 

  69. Rutz W, Walinder J, Eberhard G, et al. An educational programme on depressive disorders for general practitioners in Gotland: Background and evaluation. Acta Psychiatr Scand 1989; 79: 19–26

    Article  PubMed  CAS  Google Scholar 

  70. Bacani-Oropilla T, Lippman SB. Chronic depression: issues in long-term management. Postgrad Med 1989; 85: 171–5

    PubMed  CAS  Google Scholar 

  71. Frank E, Kupfer DJ, Perel JM, et al. Three year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990; 47: 1093–9

    Article  PubMed  CAS  Google Scholar 

  72. Prien RF, Kupfer DJ, Mansky PA, et al. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH collaborative study group comparing lithium carbonate, imipramone, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 1984; 41: 1096–104

    CAS  Google Scholar 

  73. Thase ME. Relapse and recurrence in umipolar major depression: short-term and long-term approaches. J Clin Psychiatry 1990; 51 Suppl.: 51–7

    PubMed  Google Scholar 

  74. Scott J, Eccleston D. Prediction, treatment and prognosis of chronic primary major depression. Int Clin Psychopharmacol 1991; 6 Suppl. 1:41–9

    Article  PubMed  Google Scholar 

  75. Brugha TS, Bebbington PE, MacCarthy B, et al. Antidepressants may not assist recovery in practice: a naturalistic prospective survey. Acta Psychiatr Scand 1992; 86: 5–11

    Article  PubMed  CAS  Google Scholar 

  76. Mintz J, Mintz LI, Arruda MJ, et al. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 1992; 49(10): 761–8

    Article  PubMed  CAS  Google Scholar 

  77. Shea MT, Elkin I, Imber SD, et al. Course of depressive symptoms over follow-up. Arch Gen Psychiatry 1992; 49: 782–7

    Article  PubMed  CAS  Google Scholar 

  78. Frank E, Kupfer DJ, Perel JM, et al. Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression. J Affect Disord 1993; 27: 139–45

    Article  PubMed  CAS  Google Scholar 

  79. Isacsson G, Holmgren P, Wassermen D, et al. Use of antidepressants among people committing suicide in Sweden. Br Med J 1994; 308: 506–9

    Article  CAS  Google Scholar 

  80. Simon GE, Lin EHB, Katon W, et al. Outcomes of ‘inadequate’ antidepressant treatment. J Gen Intern Med 1995; 10: 663–70

    Article  PubMed  CAS  Google Scholar 

  81. Schulberg HC, Block MR, Madonia MJ, et al. Treating major depression in primary care practice. Eight month clinical outcomes. Arch Gen Psychiatry 1996; 53: 913–9

    Article  PubMed  CAS  Google Scholar 

  82. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd rev. ed. Washington, DC: American Psychiatric Association, 1987

    Google Scholar 

  83. Lave JR, Frank RG, Schulberg HC, et al. Cost-effectiveness of treatments for major depression in primary care practice. Arch Gen Psychiatry 1998; 55: 645–51

    Article  PubMed  CAS  Google Scholar 

  84. Ali IM. Long-term treatment with antidepressants in primary care. Psychiatr Bull 1998; 22: 15–9

    Article  Google Scholar 

  85. Fish D. What is an effective dose [letter]? BMJ 1997; 314: 826

    Article  PubMed  CAS  Google Scholar 

  86. Moore MV. More on what is an effective dose [letter]. BMJ 1997; 314: 826

    Article  PubMed  CAS  Google Scholar 

  87. Tan RS. Low dose tricyclic antidepressants are effective in treating major depression [letter]. BMJ 1997; 314: 827

    PubMed  CAS  Google Scholar 

  88. Dodd GK, Berti C. A critical appraisal of a naturalistic study to support cost effective prescribing patterns of selective serotonin reuptake inhibitors in primary care. J Serotonin Res 1997; 3: 169–72

    Google Scholar 

  89. Donoghue JM. Response to: a critical appraisal of a naturalistic study to support cost effective prescribing patterns of selective serotonin reuptake inhibitors in primary care. J Serotonin Res 1997; 4: 233–7

    Google Scholar 

  90. Hotopf M, Lewis G, Normand C. Putting trials on trial — the costs and consequences of small trials in depression: a systematic review of methodology. J Epidemiol Community Health 1997; 51: 354–8

    Article  PubMed  CAS  Google Scholar 

  91. Freeman HL, O’Hanlon JF. Acute and subacute effects of antidepressants on performance. J Drug Dev Clin Pract 1995; 7: 7–20

    Google Scholar 

  92. Ray WA. Psychotropic drugs and injuries among the elderly: a review. J Clin Psychopharmacol 1992; 12: 386–96

    PubMed  CAS  Google Scholar 

  93. Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ 1995; 310: 221–4

    Article  PubMed  CAS  Google Scholar 

  94. Demyttenaere K. Compliance during treatment with antidepressants. J Affect Disord 1997; 43: 27–39

    Article  PubMed  CAS  Google Scholar 

  95. Freemantle N, House A, Mason J, et al. Economics of treatment of depression [letter]. Br J Psychiatry 1995; 166: 397

    Article  PubMed  CAS  Google Scholar 

  96. Hotopf M, Lewis G, Normand C. Are SSRIs a cost effective alternative to tricyclics? Br J Psychiatry 1996; 168: 404–9

    Article  PubMed  CAS  Google Scholar 

  97. Jonsson B, Bebbington PE. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry 1994; 164: 665–73

    Article  PubMed  CAS  Google Scholar 

  98. Le Pen C, Levy E, Ravily J, et al. The cost of treatment dropout in depression. A cost-benefit analysis of fluoxetine vs tricyclics. J Affect Disord 1994; 31: 1–18

    Article  PubMed  CAS  Google Scholar 

  99. Sclar DA, Robison LM, Skaer TL, et al. Antidepressant pharmacotherapy: economic outcomes in a health maintenance organisation. Clin Ther 1994; 16: 715–30

    PubMed  CAS  Google Scholar 

  100. Stewart A. Antidepressant pharmacotherapy: cost comparison of SSRIs and TCAs. BMJ Economics 1994; 7: 67–79

    Google Scholar 

  101. Lapierre Y, Bentkover J, Schainbaum S, et al. Direct cost of depression: analysis of treatment costs of paroxetine versus imipramine in Canada. Can J Psychiatry 1995; 40: 370–7

    PubMed  CAS  Google Scholar 

  102. Simon G, Wagner E, VonKorff M. Cost-effectiveness comparisons using ‘real world’ randomised trials: the case of new antidepressant drugs. J Clin Epidemiol 1995; 48: 363–73

    Article  PubMed  CAS  Google Scholar 

  103. Skaer TL, Sclar DA, Robison LM, et al. Economic evaluation of amitriptyline, desipramine, nortriptyline and sertraline in the management of patients with depression. Curr Ther Res 1995; 56: 556–67

    Article  Google Scholar 

  104. Forder J, Kavanagh S, Fenyo A. A comparison of the cost-effectiveness of sertraline versus tricyclic antidepressants in primary care. J Affect Disord 1996; 38: 97–111

    Article  PubMed  CAS  Google Scholar 

  105. Simon GE, VonKorff M, Heiligenstein JH, et al. Initial antidepressant choice in primary care. J Am Med Assoc 1996; 275: 1897–902

    Article  CAS  Google Scholar 

  106. Thompson D, Buesching D, Gregor KJ, et al. Patterns of antidepressant use and their relation to costs of care. Am J Manage Care 1996; 2: 1239–46

    Google Scholar 

  107. Donoghue JM. Costs of treating depression: policy should be evidence-based [commentary]. In: Maj M, Sartorius N, editors. Depressive disorders. Vol. 1. Chichester: John Wiley & Sons Ltd, 1999: 459-61 (Evidence and Experience in Psychiatry Series, World Psychiatric Association)

  108. Rosenbaum JF, Hylan TR. Costs of depressive disorders: a review. In: Maj M, Sartorius N, editors. Depressive disorders. Vol. 1. Chichester: John Wiley & Sons Ltd, 1999: 401-49 (Evidence and Experience in Psychiatry Series, World Psychiatric Association)

Download references

Author information

Authors and Affiliations

  1. PCS Health, 4 Wrenfield Grove, Liverpool, L17 9QD, England

    John Donoghue (Pharmaceutical Consultant)

  2. South London & Maudsley NHS Trust, Denmark Hill, London, England

    David M. Taylor

Authors
  1. John Donoghue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David M. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John Donoghue.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Donoghue, J., Taylor, D.M. Suboptimal Use of Antidepressants in the Treatment of Depression. Mol Diag Ther 13, 365–383 (2000). https://doi.org/10.2165/00023210-200013050-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-200013050-00006

Keywords

Search

Navigation